Raymond James & Associates’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,444
| Closed | -$310K | – | 3950 |
|
|
2021
Q2 | $310K | Buy |
+2,444
| New | +$310K | ﹤0.01% | 3393 |
|
|
2021
Q1 | – | Sell |
-1,425
| Closed | -$203K | – | 3839 |
|
|
2020
Q4 | $203K | Sell |
1,425
-11,893
| -89% | -$1.69M | ﹤0.01% | 3355 |
|
|
2020
Q3 | $940K | Buy |
13,318
+7,895
| +146% | +$557K | ﹤0.01% | 2204 |
|
|
2020
Q2 | $380K | Sell |
5,423
-1,532
| -22% | -$107K | ﹤0.01% | 2768 |
|
|
2020
Q1 | $243K | Sell |
6,955
-3,619
| -34% | -$126K | ﹤0.01% | 2897 |
|
|
2019
Q4 | $665K | Buy |
+10,574
| New | +$665K | ﹤0.01% | 2515 |
|
|
2019
Q2 | – | Sell |
-64,186
| Closed | -$1.06M | – | 3527 |
|
|
2019
Q1 | $1.06M | Buy |
64,186
+10,386
| +19% | +$172K | ﹤0.01% | 2162 |
|
|
2018
Q4 | $583K | Buy |
53,800
+39,700
| +282% | +$430K | ﹤0.01% | 2447 |
|
|
2018
Q3 | $353K | Buy |
+14,100
| New | +$353K | ﹤0.01% | 2922 |
|